Literature DB >> 3029045

Receptor alterations associated with serotonergic agents: an autoradiographic analysis.

J K Wamsley, W F Byerley, R T McCabe, E J McConnell, T M Dawson, B I Grosser.   

Abstract

Controversy exists concerning whether receptor down-regulation is involved in the efficacy of antidepressants. Many investigators believe that norepinephrine (NE) receptor down-regulation is more important than serotonin (5-HT) receptor down-regulation. The ability to accurately determine which receptor types or subtypes have been down-regulated has been impaired by the lack of sufficiently specific ligands for labeling these receptor subtypes. Studies that have attempted to examine 5-HT2 receptor down-regulation have used [3H]-ketanserin as the ligand of choice to label 5-HT2 receptors, but this ligand also labels a nondescript site. The binding of [3H]-ketanserin to sites other than 5-HT2 receptors can be examined and controlled for by autoradiographic techniques. The authors briefly review potential problems involved in analyzing receptor binding after antidepressant treatment and present new findings of receptor alterations in rat brain as examined by autoradiographic techniques following chronic exposure to fluoxetine (a selective 5-HT uptake inhibitor that has been shown to be an effective antidepressant). Laboratory animals injected with fluoxetine showed receptor down-regulation (reduced density) in the serotonergic system. A provocative and potentially important finding of this study is that this selective 5-HT uptake blocker also down-regulates beta-adrenergic receptors in the CNS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029045

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.

Authors:  A A Alhaider; A A Mustafa
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administration.

Authors:  Gerard J Marek
Journal:  Neurosci Lett       Date:  2008-04-24       Impact factor: 3.046

3.  Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments.

Authors:  E P Pälvimäki; A Laakso; M Kuoppamäki; E Syvälahti; J Hietala
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

4.  Pharmacologic specificity of antidepressive activity by monoaminergic neural transplants.

Authors:  D D Dougherty; C E Sortwell; J Sagen
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 5.  Clinical pharmacokinetics of fluoxetine.

Authors:  A C Altamura; A R Moro; M Percudani
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

6.  Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain.

Authors:  K G Todd; D J McManus; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1995-06       Impact factor: 5.046

Review 7.  Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.

Authors:  J L Jarry; F J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

Review 8.  Antidepressant drugs and the emergence of suicidal tendencies.

Authors:  M H Teicher; C A Glod; J O Cole
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

Review 9.  Fluoxetine: a review of receptor and functional effects and their clinical implications.

Authors:  C M Beasley; D N Masica; J H Potvin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 10.  Molecular mechanism of noradrenaline during the stress-induced major depressive disorder.

Authors:  Kenjiro Seki; Satomi Yoshida; Manoj Kumar Jaiswal
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.